The Centers for Medicare & Medicaid Services (CMS) reported that between 2002 and 2010, elderly healthcare spending grew at the slowest rate among all age groups, which, according to CMS, can be attributed to the recession.
The Centers for Medicare & Medicaid Services (CMS) reported that between 2002 and 2010, elderly healthcare spending grew at the slowest rate among all age groups, which, according to CMS, can be attributed to the recession. This information comes from a subset of the National Health Expenditure (NHE) data report, which measures healthcare spending in the United States. It gathers and determines annual spending by gender and major age groups.
During this 8-year period, the average spending per individual for those 65 years and older rose only 4.1%. CMS officials determined that spending for nursing homes, continuing care programs for the elderly, and Medicare managed care payments also slowed. They said that lower overall spending among the elderly likely contributed to the deceleration.
The data set presented additional findings that documented the impact of Medicare’s 2006 prescription drug coverage expansion. Medicare spending on drugs increased from $3.4 billion in 2004 (5% of overall spending) to $39.6 billion in 2006. By 2010, 54% of drug spending was allocated to Medicare beneficiaries. As well, the gap in prescription spending between men and women narrowed from 38% to 25%, suggesting that men may be more likely to fill their prescriptions
.
An official CMS statement provided other highlights from the data:
Around the Web
Elderly Healthcare Spending Grew at Slowest Rate Among All Age Groups Between 2002-2010
Per Capita Health Spending for Elderly Grows at Lowest Rate among all Age Groups from 2002-2010 [CMS]
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More